NA Refractive Surgery Devices Market - Industry Trends and Forecast to 2029

TABLE OF CONTENT

TABLE OF CONTENTS
1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.3 OVERVIEW OF NORTH AMERICA REFRACTIVE SURGERY DEVICES MARKET 28
1.4 LIMITATIONS 30
1.5 MARKETS COVERED 30
2 MARKET SEGMENTATION 32
2.1 MARKETS COVERED 32
2.2 GEOGRAPHICAL SCOPE 33
2.3 YEARS CONSIDERED FOR THE STUDY 34
2.4 CURRENCY AND PRICING 34
2.5 DBMR TRIPOD DATA VALIDATION MODEL 35
2.6 MULTIVARIATE MODELLING 38
2.7 PRODUCT TYPE LIFELINE CURVE 39
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 40
2.9 DBMR MARKET POSITION GRID 41
2.10 MARKET APPLICATION COVERAGE GRID 42
2.11 VENDOR SHARE ANALYSIS 43
2.12 SECONDARY SOURCES 44
2.13 ASSUMPTIONS 44
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHTS 48
4.1 PESTEL'S MODEL 50
4.2 PORTER'S FIVE FORCES MODEL 51
4.3 NORTH AMERICA REFRACTIVE SURGERY DEVICES MARKET: REGULATIONS 52
4.3.1 REGULATION IN THE U.S. 52
4.3.2 REGULATIONS IN EUROPE 53
4.3.3 REGULATIONS IN SINGAPORE 53
4.3.4 REGULATIONS IN AUSTRALIA 54
5 MARKET OVERVIEW 55
5.1 DRIVERS 57
5.1.1 INCREASING TECHNOLOGICAL ADVANCEMENT 57
5.1.2 RISE IN HEALTHCARE EXPENDITURE 57
5.1.3 INCREASE IN POPULATION WITH MACULAR DEGENERATION 57
5.1.4 RISE IN ADOPTION OF MINIMALLY INVASIVE SURGERIES 58
5.2 RESTRAINTS 58
5.2.1 STRINGENT RULES AND REGULATIONS 58
5.2.2 HIGH COST ASSOCIATED WITH REFRACTIVE SURGERY DEVICES 59
5.2.3 SIDE EFFECTS OF SURGERY 59
5.3 OPPORTUNITIES 61
5.3.1 ACHIEVEMENTS IN LASIK SURGERIES 61
5.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS 61
5.3.3 INCREASING GERIATRIC POPULATION 62
5.3.4 EXCESSIVE USAGE OF DIGITAL DEVICES 62
5.4 CHALLENGES 64
5.4.1 DEARTH OF SKILLED PROFESSIONALS 64
5.4.2 LACK OF HEALTHCARE FACILITIES FOR EYE TREATMENT 64
6 COVID-19 IMPACT ON NORTH AMERICA REFRACTIVE SURGERY DEVICES MARKET 65
6.1 IMPACT ON PRICE 65
6.2 IMPACT ON DEMAND 65
6.3 IMPACT ON SUPPLY 66
6.4 STRATEGIC DECISIONS BY MANUFACTURERS 66
6.5 CONCLUSION 67
7 NORTH AMERICA REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE 68
7.1 OVERVIEW 69
7.2 LASER 72
7.2.1 EXCIMER LASERS 73
7.2.2 FEMTOSECOND LASER/ULTRASHORT PULSE LASER 73
7.2.3 OTHERS 74
7.3 PHAKIC INTRAOCULAR LENS (IOL) 74
7.4 ABERROMETERS / WAVEFRONT ABERROMETRY 75
7.5 SURGICAL INSTRUMENTS & ACCESSORIES 75
7.6 REFRACTIVE SURGERY KITS 76
7.7 PUPILLARY DIAMETER METERS 77
7.8 EPIKERATOMES 78
7.9 MICROKERATOMES 79
7.10 THERMOKERATOPLASTY 79
7.11 LIMBAL RELAXING INCISION KITS 80
7.12 OTHERS 81

8 NORTH AMERICA REFRACTIVE SURGERY DEVICES DISEASE MARKET, BY SURGERY TYPE 83
8.1 OVERVIEW 84
8.2 LASIK (LASER IN-SITU KERATOMILEUSIS) 87
8.3 PHOTOREFRACTIVE KERATECTOMY (PRK) 88
8.4 PHAKIC INTRAOCULAR LENSES (IOL) 89
8.5 ASTIGMATIC KERATOTOMY (AK) 90
8.6 AUTOMATED LAMELLAR KERATOPLASTY (ALK) 91
8.7 INTRACORNEAL RING (INTACS) 92
8.8 LASER THERMAL KERATOPLASTY (LTK) 93
8.9 CONDUCTIVE KERATOPLASTY (CK) 94
8.10 RADIAL KERATOTOMY (RK) 95
8.11 OTHERS 96
9 NORTH AMERICA REFRACTIVE SURGERY DEVICES DISEASE MARKET, BY APPLICATION 98
9.1 OVERVIEW 99
9.2 NEARSIGHTEDNESS (MYOPIA) 102
9.3 FARSIGHTEDNESS (HYPEROPIA) 102
9.4 PRESBYOPIA 103
9.5 ASTIGMATISM 104
10 NORTH AMERICA REFRACTIVE SURGERY DEVICES DISEASE MARKET, BY END USER 106
10.1 OVERVIEW 107
10.2 HOSPITAL 110
10.3 SPECIALTY CLINICS 110
10.4 AMBULATORY SURGICAL CENTERS 111
10.5 OTHERS 112
11 NORTH AMERICA REFRACTIVE SURGERY DEVICES DISEASE MARKET, BY DISTRIBUTION CHANNEL 113
11.1 OVERVIEW 114
11.2 DIRECT TENDER 117
11.3 THIRD PARTY DISTRIBUTORS 117
11.4 OTHERS 118

12 NORTH AMERICA REFRACTIVE SURGERY DEVICES MARKET, BY REGION 120
12.1 NORTH AMERICA 121
12.1.1 U.S. 130
12.1.2 CANADA 133
12.1.3 MEXICO 136
13 NORTH AMERICA REFRACTIVE SURGERY DEVICES MARKET: COMPANY LANDSCAPE 139
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 139
14 SWOT ANALYSIS 140
15 COMPANY PROFILE 141
15.1 JOHNSON AND JOHNSON SERVICES, INC. 141
15.1.1 COMPANY SNAPSHOT 141
15.1.2 REVENUE ANALYSIS 141
15.1.3 COMPANY SHARE ANALYSIS 142
15.1.4 PRODUCT PORTFOLIO 143
15.1.5 RECENT DEVELOPMENT 143
15.1.5.1 PRODUCT LAUNCH 143
15.2 ALCON INC. 144
15.2.1 COMPANY SNAPSHOT 144
15.2.2 REVENUE ANALYSIS 145
15.2.3 COMPANY SHARE ANALYSIS 145
15.2.4 PRODUCT PORTFOLIO 146
15.2.5 RECENT DEVELOPMENTS 146
15.2.5.1 ACQUISITION 146
15.2.5.2 PRODUCT LAUNCH 147
15.3 STAAR SURGICAL 148
15.3.1 COMPANY SNAPSHOT 148
15.3.2 REVENUE ANALYSIS 148
15.3.3 COMPANY SHARE ANALYSIS 149
15.3.4 PRODUCT PORTFOLIO 149
15.3.5 RECENT DEVELOPMENTS 150
15.4 BAUSCH + LOMB INCORPORATED 151
15.4.1 COMPANY SNAPSHOT 151
15.4.2 REVENUE ANALYSIS 151
15.4.3 COMPANY SHARE ANALYSIS 152
15.4.4 PRODUCT PORTFOLIO 152
15.4.5 RECENT DEVELOPMENT 153
15.4.5.1 ACQUISITION 153
15.4.5.2 CE APPROVAL 153
15.5 TOPCON CANADA INC., (A SUBSIDIARY OF TOPCON CORPORATION) 154
15.5.1 COMPANY SNAPSHOT 154
15.5.2 REVENUE ANALYSIS 154
15.5.3 COMPANY SHARE ANALYSIS 155
15.5.4 PRODUCT PORTFOLIO 155
15.5.5 RECENT DEVELOPMENTS 156
15.5.5.1 PARTNERSHIP 156
15.5.5.2 ACQUISITION 157
15.6 AAREN SCIENTIFIC INC. 158
15.6.1 COMPANY SNAPSHOT 158
15.6.2 PRODUCT PORTFOLIO 159
15.6.3 RECENT DEVELOPMENT 159
15.7 AMPLITUDE LASER 160
15.7.1 COMPANY SNAPSHOT 160
15.7.2 PRODUCT PORTFOLIO 160
15.7.3 RECENT DEVELOPMENTS 160
15.7.3.1 PARTNERSHIP 161
15.8 BD 163
15.8.1 COMPANY SNAPSHOT 163
15.8.2 REVENUE ANALYSIS 163
15.8.3 PRODUCT PORTFOLIO 164
15.8.4 RECENT DEVELOPMENTS 164
15.8.4.1 CONFERENCE 164
15.8.4.2 PRODUCT LAUNCH 164
15.9 GLAUKOS CORPORATION 165
15.9.1 COMPANY SNAPSHOT 165
15.9.2 REVENUE ANALYSIS 165
15.9.3 PRODUCT PORTFOLIO 166
15.9.4 RECENT DEVELOPMENTS 166
15.9.4.1 PRODUCT LAUNCH 166
15.9.4.2 ACQUISITION 167
15.10 HOYA SURGICAL OPTICS 168
15.10.1 COMPANY SNAPSHOT 168
15.10.2 PRODUCT PORTFOLIO 168
15.10.3 RECENT DEVELOPMENT 169
15.10.3.1 CONFERENCE 169

15.11 IVIS TECHNOLOGIES 170
15.11.1 COMPANY SNAPSHOT 170
15.11.2 PRODUCT PORTFOLIO 170
15.11.3 RECENT DEVELOPMENTS 171
15.12 LENSAR INC. (A SUBSDIARY OF PDL BIOPHARMA, INC.) 172
15.12.1 COMPANY SNAPSHOT 172
15.12.2 PRODUCT PORTFOLIO 172
15.12.3 RECENT DEVELOPMENTS 172
15.13 MORIA 173
15.13.1 COMPANY SNAPSHOT 173
15.13.2 PRODUCT PORTFOLIO 174
15.13.3 RECENT DEVELOPMENT 174
15.14 NIDEK CO., LTD 175
15.14.1 COMPANY SNAPSHOT 175
15.14.2 PRODUCT PORTFOLIO 175
15.14.3 RECENT DEVELOPMENT 175
15.14.3.1 WEBSITE LAUNCH 175
15.15 OPHTEC BV 176
15.15.1 COMPANY SNAPSHOT 176
15.15.2 PRODUCT PORTFOLIO 176
15.15.3 RECENT DEVELOPMENT 177
15.15.3.1 PRODUCT LAUNCH 177
15.16 RAYNER INTRAOCULAR LENSES LIMITED 178
15.16.1 COMPANY SNAPSHOT 178
15.16.2 PRODUCT PORTFOLIO 178
15.16.3 RECENT DEVELOPMENTS 178
15.16.3.1 NEW DISTRIBUTION UNIT 178
15.16.3.2 ACQUISITION 179
15.16.3.3 ACQUISITION 179
15.17 REICHERT, INC. 180
15.17.1 COMPANY SNAPSHOT 180
15.17.2 PRODUCT PORTFOLIO 180
15.17.3 RECENT DEVELOPMENT 180
15.17.3.1 CONFERENCE 180
15.18 ROWIAK GMBH 181
15.18.1 COMPANY SNAPSHOT 181
15.18.2 PRODUCT PORTFOLIO 181
15.18.3 RECENT DEVELOPMENT 181
15.18.3.1 R&D FACILITY 181

15.19 SCHWIND EYE-TECH-SOLUTIONS 182
15.19.1 COMPANY SNAPSHOT 182
15.19.2 PRODUCT PORTFOLIO 182
15.19.3 RECENT DEVELOPMENTS 183
15.20 TRACEY TECHNOLOGIES 184
15.20.1 COMPANY SNAPSHOT 184
15.20.2 PRODUCT PORTFOLIO 184
15.20.3 RECENT DEVELOPMENT 184
15.20.3.1 R&D FACILITY 184
15.21 ZIEMER OPHTHALMIC SYSTEMS 185
15.21.1 COMPANY SNAPSHOT 185
15.21.2 PRODUCT PORTFOLIO 185
15.21.3 RECENT DEVELOPMENT 185
15.21.3.1 AGREEMENT 186
16 QUESTIONNAIRE 187
17 RELATED REPORTS 191